56 related articles for article (PubMed ID: 926384)
1. [Mumps virus therapy of neoplasms (1)].
Okuno Y; Asada T; Yamanishi K; Otsuka E; Takahashi M
Nihon Rinsho; 1977 Sep; 35(9):2867-72. PubMed ID: 926384
[No Abstract] [Full Text] [Related]
2. [Mumps virus therapy of neoplasms (2)].
Okuno Y; Asada T; Yamanishi K; Otsuka T; Takahashi M; Tanioka T; Aoyama H; Fukui O; Matsumoto K; Uemura F; Wada A
Nihon Rinsho; 1977; 35(10):3820-5. PubMed ID: 604530
[No Abstract] [Full Text] [Related]
3. Differences in antibody response induced by formaldehyde inactivated and live mumps vaccines.
Penttinen K; Helle EP; Norrby E
Dev Biol Stand; 1979; 43():265-8. PubMed ID: 391631
[No Abstract] [Full Text] [Related]
4. Prevalence of antibodies against measles, mumps and rubella in Israeli young adults.
Danon YL; Adir Y; Abend I; Zaaide Y; Green MS
Isr J Med Sci; 1992 Oct; 28(10):733-6. PubMed ID: 1399506
[No Abstract] [Full Text] [Related]
5. Transmission of live, attenuated mumps virus to the human placenta.
Yamauchi T; Wilson C; Geme JW
N Engl J Med; 1974 Mar; 290(13):710-2. PubMed ID: 4813744
[No Abstract] [Full Text] [Related]
6. Horizontal transmission of the Leningrad-Zagreb mumps vaccine strain: a report of three cases.
Tesović G; Poljak M; Lunar MM; Kocjan BJ; Seme K; Vukić BT; Sternak SL; Cajić V; Vince A
Vaccine; 2008 Apr; 26(16):1922-5. PubMed ID: 18329761
[No Abstract] [Full Text] [Related]
7. Mumps vaccine failure investigation in Novosibirsk, Russia, 2002-2004.
Atrasheuskaya AV; Kulak MV; Rubin S; Ignatyev GM
Clin Microbiol Infect; 2007 Jul; 13(7):670-6. PubMed ID: 17484765
[TBL] [Abstract][Full Text] [Related]
8. Horizontal transmission of the Leningrad-3 live attenuated mumps vaccine virus.
Atrasheuskaya AV; Neverov AA; Rubin S; Ignatyev GM
Vaccine; 2006 Mar; 24(10):1530-6. PubMed ID: 16266774
[TBL] [Abstract][Full Text] [Related]
9. Interstrain antigenic variability of mumps viruses.
Heininger U; Bonhoeffer J
Clin Infect Dis; 2008 Jan; 46(1):150-1. PubMed ID: 18171235
[No Abstract] [Full Text] [Related]
10. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
Zäch K; Nicoara C; Germann D; Matter L
Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
[TBL] [Abstract][Full Text] [Related]
11. Investigation of mumps vaccine failures in Minsk, Belarus, 2001-2003.
Atrasheuskaya AV; Blatun EM; Kulak MV; Atrasheuskaya A; Karpov IA; Rubin S; Ignatyev GM
Vaccine; 2007 Jun; 25(24):4651-8. PubMed ID: 17498853
[TBL] [Abstract][Full Text] [Related]
12. Studies on live attenuated mumps vaccine. III. Long-term follow-up study on the efficacy of Biken vaccine.
Isomura S; Miyazu M; Nagai H; Naruse H; Shibata M; Ichikawa T; Suzuki S; Yamanishi K; Takahashi M
Biken J; 1982 Jun; 25(2):63-9. PubMed ID: 7138492
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of mumps virus genome and application of the PCR for identification of the mumps virus strains].
Tanabayashi K; Yamada A
Nihon Rinsho; 1992 Jul; 50 Suppl():244-9. PubMed ID: 1404910
[No Abstract] [Full Text] [Related]
14. Prevalence of IgG-antibodies to mumps and measles virus in non-vaccinated children.
Glikmann G; Petersen I; Mordhorst CH
Dan Med Bull; 1988 Apr; 35(2):185-7. PubMed ID: 3359817
[TBL] [Abstract][Full Text] [Related]
15. Studies on the use of mumps virus for treatment of human cancer.
Okuno Y; Asada T; Yamanishi K; Otsuka T; Takahashi M; Tanioka T; Aoyama H; Fukui O; Matsumoto K; Uemura F; Wada A
Biken J; 1978 Jun; 21(2):37-49. PubMed ID: 749908
[TBL] [Abstract][Full Text] [Related]
16. [Mumps].
Olivier C
Rev Prat; 2002 Sep; 52(13):1489-92. PubMed ID: 12385161
[No Abstract] [Full Text] [Related]
17. Mumps control today.
Quinlisk MP
J Infect Dis; 2010 Sep; 202(5):655-6. PubMed ID: 20662719
[No Abstract] [Full Text] [Related]
18. [MUMPS].
Takita S
Nihon Rinsho; 2003 Feb; 61 Suppl 2():271-5. PubMed ID: 12722227
[No Abstract] [Full Text] [Related]
19. Detection of postvaccination mumps virus antibody by neutralization test, enzyme-linked immunosorbent assay and sensitive hemagglutination inhibition test.
Fedová D; Brůcková M; Plesník V; Slonim D; Sejda J; Svandová E; Kubínová I
J Hyg Epidemiol Microbiol Immunol; 1987; 31(4):409-22. PubMed ID: 3429853
[TBL] [Abstract][Full Text] [Related]
20. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
